DPP-4-IN-17
DPP-4-IN-17 is an orally active and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 value of 0.12 nM. DPP-4-IN-17 increases the enzyme's Km value (75.73 μM vs. 27.18 μM of substrate alone) and reduces catalytic efficiency. DPP-4-IN-17 reduces blood glucose levels and reverses weight loss in Streptozotocin (STZ) /Nicotinamide (NA) (HY-B0150) -induced diabetic rats. DPP-4-IN-17 can be used for the study of type 2 diabetes mellitus (T2DM).
Product Specifications
UNSPSC
12352100
Target
Dipeptidyl Peptidase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
COC([C@@H]1CCCN1C([C@@H](NC([C@@H]2CCCN2C(OC(C)(C)C)=O)=O)CCCCNC([C@@H]3CCCN3C(OC(C)(C)C)=O)=O)=O)=O
Molecular Formula
C32H53N5O9
Molecular Weight
651.79
References & Citations
[1]Jaglan S, et al. Rationally designed small peptides targeting DPP-4: Identification of potent anti-diabetic agents. Bioorg Chem. 2025 Aug;163:108781.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DPP-4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
583908-01 20 µg
Carbonic Anhydrase 1, Recombinant, Rat, aa2-261, His-SUMO-Tag
Sign In for Pricing
View Details 583908-02 100 µg
Carbonic Anhydrase 1, Recombinant, Rat, aa2-261, His-SUMO-Tag
Sign In for Pricing
View Details 
TRC-A179140-250MG 250 mg
4-(4-Acetyl-3-hydroxy-2-propylphenoxy)butanoic Acid Ethyl Ester
Sign In for Pricing
View Details